China SXT Pharmaceuticals, Inc. (SXTC) stock
SXTCNasdaqPharmaceutical PreparationsFiscal year ends March 31
$2.83−0.03 (-1.05%)
Close on Nov 18, 2026Market cap $2.71MP/E –Yield –
China SXT Pharmaceuticals net income
Net income is the profit left for shareholders after every expense, interest and tax.
For fiscal 2026 it was -$6.21M. The highest annual figure on record is $1.54M in fiscal 2019.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | -$6.21M | – |
| FY2025 | Mar 31, 2025 | -$3.30M | – |
| FY2024 | Mar 31, 2024 | -$3.10M | – |
| FY2023 | Mar 31, 2023 | -$5.93M | – |
| FY2022 | Mar 31, 2022 | -$5.74M | – |
| FY2021 | Mar 31, 2021 | -$2.75M | – |
| FY2020 | Mar 31, 2020 | -$10.29M | -768.4% |
| FY2019 | Mar 31, 2019 | $1.54M | +29.6% |
| FY2018 | Mar 31, 2018 | $1.19M | +0.2% |
| FY2017 | Mar 31, 2017 | $1.19M | – |
See a number that looks wrong?